# DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

> clinical trial · VERIFIED · 2026-07-20

Status: RECRUITING · Sponsor: Diakonos Oncology Corporation · Condition: Refractory Melanoma

- Company: Diakonos Oncology Corporation
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07288112

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.